N-Nitroso Oxomemazine
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

N-Nitroso Oxomemazine

● In Stock

Catalogue No.:VE0011308
CAS No.:N/A
Mol. Formula:C17H19N3O3S
Mol. Weight:345.42 g/mol

Additional information on N-Nitroso Oxomemazine

Parent drug

Oxomemazine

IUPAC Name

N-(3-(5, 5-dioxido-10H-phenothiazin-10-yl)-2-methylpropyl)-N-methylnitrous amide

Pharmacopoeial Synonyms

N/A

Other Synonyms

N-Nitroso N-desmethyl Oxomemazine

Smiles

O=NN(CC(C)CN1C2=C(C=CC=C2)S(C3=CC=CC=C13)(=O)=O)C

InChl

InChI=1S/C17H19N3O3S/c1-13(11-19(2)18-21)12-20-14-7-3-5-9-16(14)24(22,23)17-10-6-4-8-15(17)20/h3-10,13H,11-12H2,1-2H3

Description

N-Nitroso Oxomemazine is an N-nitroso derivative of the secondary amine present in Oxomemazine | which is a highly characterized reference material that meets stringent regulatory standards set for nitrosamine compounds | including those set by USP | EMA | JP | and BP. This nitroso standard is essential for a variety of applications | such as analytical method development | method validation (AMV) | and Quality Control (QC) | particularly in the context of Oxomemazine production. It is suitable for use in both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). This nitrosamine standard helps establish detection limits | quantify impurity levels | and ensure trace nitroso impurities in pharmaceutical products remain within FDA and EMA safety limits.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
Products quotation
Name
Url
 
This field is hidden when viewing the form
This field is hidden when viewing the form